<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) and (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)*
OptiCare Health Systems, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.001 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
68386P105
--------------------------------------------------------------------------------
(CUSIP Number)
October 10, 2000
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|X| Rule 13d-1(c)
|_| Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 (the "Act") or otherwise subject to the liabilities of that section
of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 6
<PAGE>
------------------------------- -----------------------------
CUSIP NO. 68386P105 13G Page 2 of 7 Pages
------------------------------- -----------------------------
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NUMBER OF ABOVE PERSON (ENTITIES ONLY)
Nicolas Berggruen
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
-0-
NUMBER OF
SHARES ----------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 2,404,026
REPORTING
PERSON ----------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
-0-
----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,404,026
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,404,026
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
[ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
19.1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
--------------------------------------------------------------------------------
<PAGE>
------------------------------- -----------------------------
CUSIP NO. 68386P105 13G Page 3 of 7 Pages
------------------------------- -----------------------------
This initial statement on Schedule 13G is being filed
pursuant to Rule 13d-1(c) under the Securities Exchange Act of
1934, as amended, by Nicolas Berggruen ("Berggruen").
Capitalized terms used but not otherwise defined herein shall
have the meaning ascribed to such terms in the Schedule 13G.
The Schedule 13G is hereby amended and supplemented as
follows:
Item 1(a). Name of Issuer:
OptiCare Health Systems, Inc.
Item 1(b). Address of Issuer's Principal Executive Offices:
87 Grandview Avenue
Waterbury, CT 06708
Item 2(a). Name of Persons Filing:
Nicolas Berggruen
Item 2(b). Address of Principal Business Office or, if none, Residence:
499 Park Avenue
New York, New York 10022
Item 2(c). Citizenship:
United States of America
<PAGE>
------------------------------- -----------------------------
CUSIP NO. 68386P105 13G Page 4 of 7 Pages
------------------------------- -----------------------------
Item 3. If this statement is filed pursuant to Rule 13d-1(b), or
13d-2(b) or (c), Check Whether the Person Filing is a:
This statement is filed on behalf of Berggruen pursuant to
Rule 13d-1(c).
Item 4. Ownership.
(a) Amount Beneficially Owned:
Berggruen is deemed to beneficially own 2,404,026 shares of
Common Stock. Of the 2,404,026 shares of Common Stock deemed
beneficially owned by Berggruen, 2,250,000 are shares of
Common Stock that Medici I Investment Corp. can purchase under
warrants at an exercise price of $1.00 per share, exercisable
until October 1, 2005, and 154,026 are shares of Common Stock
held by Alexander Enterprise Holding Corp.
(b) Percent of Class:
The 2,404,026 shares of Common Stock deemed beneficially owned
by Berggruen constitute approximately 19.1% of the issued and
outstanding shares of Common Stock.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote
0
<PAGE>
------------------------------- -----------------------------
CUSIP NO. 68386P105 13G Page 5 of 7 Pages
------------------------------- -----------------------------
(ii) shared power to vote or to direct the vote
2,404,026
(iii) sole power to dispose or to direct the
disposition of
0
(iv) shared power to dispose or to direct the
disposition of
2,404,026
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact
that as of the date hereof the reporting person has ceased to
be the beneficial owner of more than five percent of the class
of securities, check the following [ ].
Item 6. Ownership of More than Five Percent on Behalf of Another
Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company or Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
<PAGE>
------------------------------- -----------------------------
CUSIP NO. 68386P105 13G Page 6 of 7 Pages
------------------------------- -----------------------------
Item 10. Certification.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were not acquired
and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the
securities and were not acquired and are not held in
connection with or as a participant in any transaction having
that purpose or effect.
<PAGE>
------------------------------- -----------------------------
CUSIP NO. 68386P105 13G Page 7 of 7 Pages
------------------------------- -----------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated: October 20, 2000
By: /s/ Nicolas Berggruen
--------------------------
Nicolas Berggruen
